Skip to Content

Newsletter No. 16 -- April, 1999

ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:

NIH

  1. PLANNING GRANTS: IN VIVO CELLULAR AND MOLECULAR IMAGING CENTERS (PRE-ICMICs) NCI (RFA: CA-99-002)
    Letter of Intent Receipt Date: June 17, 1999; Application Receipt Date: July 23, 1999
    The Diagnostic Imaging Program, Division of Cancer Diagnosis and Treatment of the National Cancer Institute (NCI) invites applications for P20 planning grants that lead to the establishment of In Vivo Cellular and Molecular Imaging Centers. See below.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-99-002.html
  2. IN VIVO CELLULAR AND MOLECULAR IMAGING CENTERS (ICMICs) NCI (RFA: CA-99-004)
    Letter of Intent Receipt Date: June 17, 1999; Application Receipt Date: July 23, 1999
    The Diagnostic Imaging Program, Division of Cancer Diagnosis and Treatment of the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for the establishment of In Vivo Cellular and Molecular Imaging Centers (ICMICs). These initiatives are designed to capitalize on the extraordinary opportunity for studying cancer non-invasively, and in many cases, quantitatively due to recent advances in molecular imaging modalities, molecular and cellular biology. They will facilitate the interaction of scientists from a variety of fields such as, but not limited to: imaging sciences, chemistry, radiopharmaceutical chemistry, cell and molecular biology, pharmacology, computer science, biomedical engineering, immunology and neuroscience, and provide resources to conduct multidisciplinary research.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-99-004.html
  3. RADIATION DOSIMETRY FOR EPIDEMIOLOGIC STUDIES NCI
    RFP AVAILABLE: N01-CP-91024-21
    Responses will be due May 5, 1999 (or 45 days from actual release date of RFP).
    The National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics Program (DCEG), Radiation Epidemiology Branch (REB) is recompeting a requirement to continue dosimetry support for epidemiologic studies of populations exposed to ionizing radiation, conducted by the REB. The current contract (Number N01-CP-40535) with the University of Texas, M.D. Anderson Cancer Center, is scheduled to expire September 24, 1999. This project is essential to REB's ability to quantify radiation risks and provide information on dose-response relationships.
    Electronic RFP at URL: http://www.peacetech.com/Rcab/rfps_published.asp
    NIH Guide notice at: http://grants.nih.gov/grants/guide/notice-files/not99-047.html
  4. NCI Initiatives Applicable to Breast Cancer Research
    There is an announcement by the National Cancer Institute (NCI) to acquaint breast cancer investigators with the diverse opportunities supported by the NCI that either address general research themes or are specific to breast cancer research. The complete announcement, NCI Initiatives Applicable to Breast Cancer Research, is available only from the NCI homepage.
    URL: http://www.cancer.gov/
  5. CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM - NIH
    PA NUMBER: PAR-99-077
    National Cancer Institute
    Letter of Intent Receipt Date: September 7, 1999, May 1, 2000, May 1, 2001
    Application Receipt Date: October 1, 1999; June 1, 2000; June 1, 2001
    This Program Announcement (PA) replaces RFA CA-97-008, Clinical Oncology Research Career Development Program, which was published in the NIH Guide, Vol.26, No. 3, January 31, 1997.
    The purpose of the National Cancer Institute (NCI) Clinical Oncology Career Development Program is to increase the number of medical doctors (M.D.'s, D.O.'s) and doctorally degreed Oncology registered nurses.
    URL : http://grants.nih.gov/grants/guide/pa-files/PAR-99-077.html
  6. NIH-Duke Training Program in Clinical Research
    Application deadline: April 15, 1999; Notification date: July 1, 1999
    Applications are now being accepted for the 1999-2000 NIH-Duke Training Program in Clinical Research. The program, designed primarily for clinical fellows and other health professionals who are training for careers in clinical research, offers formal courses in research design, statistical analysis, health economics, research ethics, and research management. Academic credit earned by participating in this program may be applied toward satisfying the degree requirement for a Master of Health Sciences in Clinical Research from Duke University School of Medicine.
    For additional information regarding course work and tuition costs for the 1999-2000 academic year, please refer to the program website at http://www.cc.nih.gov./ccc/cc_duke/info.html
  7. BRCA Chips Available: Francis Collins, Director of NHGRI, has possession of a supply of Affymetrix BrCa1 and 2 arrays for resequencing that he had made for a purpose for which they will no longer be used. He is looking for people who might have a use for them. If any projects (or grantees) that might have a use for these, feel free to inquire from Dr. Collins directly. His e-mail address is fc23a@nih.gov

___________________________________

The Diagnostic Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary.

If you wish to be added to the list (or removed from it), please contact Johnnie Smith by return e-mail (js95x@nih.gov).

The staff of the Diagnostic Imaging Program places a high priority on communicating with and facilitating the work of researchers in the imaging community. We look forward to working with you.

Diagnostic Imaging Program Division of Cancer Treatment and Diagnosis, NCI Executive Plaza North, Room 800 6130 Executive Boulevard Rockville, MD 20892-7440 Tel: 301 496 9531 Fax: 301 480 5785